Cooper Companies Inc (COO) Shares Bought by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC grew its stake in Cooper Companies Inc (NYSE:COO) by 24.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,282 shares of the medical device company’s stock after purchasing an additional 837 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Cooper Companies were worth $979,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. grew its position in shares of Cooper Companies by 0.9% in the first quarter. BlackRock Inc. now owns 3,647,931 shares of the medical device company’s stock valued at $834,681,000 after purchasing an additional 31,592 shares during the period. Massachusetts Financial Services Co. MA boosted its position in Cooper Companies by 4.6% during the first quarter. Massachusetts Financial Services Co. MA now owns 2,730,859 shares of the medical device company’s stock worth $624,849,000 after acquiring an additional 119,970 shares during the last quarter. Amundi Pioneer Asset Management Inc. boosted its position in Cooper Companies by 10.1% during the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 1,379,094 shares of the medical device company’s stock worth $300,476,000 after acquiring an additional 126,156 shares during the last quarter. Westfield Capital Management Co. LP boosted its position in Cooper Companies by 19.9% during the first quarter. Westfield Capital Management Co. LP now owns 710,938 shares of the medical device company’s stock worth $162,670,000 after acquiring an additional 117,982 shares during the last quarter. Finally, Frontier Capital Management Co. LLC boosted its position in Cooper Companies by 6.6% during the first quarter. Frontier Capital Management Co. LLC now owns 699,460 shares of the medical device company’s stock worth $160,043,000 after acquiring an additional 43,009 shares during the last quarter. Institutional investors and hedge funds own 96.85% of the company’s stock.

Shares of Cooper Companies opened at $234.81 on Wednesday, MarketBeat reports. The company has a current ratio of 2.76, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. Cooper Companies Inc has a 12 month low of $216.47 and a 12 month high of $260.26. The stock has a market cap of $11.65 billion, a price-to-earnings ratio of 24.21, a PEG ratio of 1.87 and a beta of 0.61.

Cooper Companies (NYSE:COO) last issued its earnings results on Thursday, June 7th. The medical device company reported $2.86 EPS for the quarter, topping analysts’ consensus estimates of $2.84 by $0.02. Cooper Companies had a net margin of 5.58% and a return on equity of 17.14%. The company had revenue of $631.30 million for the quarter, compared to the consensus estimate of $627.49 million. During the same period in the previous year, the firm earned $2.50 earnings per share. Cooper Companies’s quarterly revenue was up 20.8% compared to the same quarter last year. research analysts anticipate that Cooper Companies Inc will post 11.81 EPS for the current fiscal year.

In other Cooper Companies news, Director Allan E. Rubenstein sold 1,000 shares of Cooper Companies stock in a transaction dated Friday, June 15th. The shares were sold at an average price of $235.13, for a total transaction of $235,130.00. Following the transaction, the director now directly owns 4,568 shares of the company’s stock, valued at $1,074,073.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Michael Kalkstein sold 1,715 shares of Cooper Companies stock in a transaction dated Wednesday, April 11th. The stock was sold at an average price of $221.66, for a total transaction of $380,146.90. The disclosure for this sale can be found here. Insiders have sold 3,145 shares of company stock worth $716,039 over the last ninety days. 1.60% of the stock is owned by insiders.

A number of equities analysts recently weighed in on COO shares. TheStreet upgraded shares of Cooper Companies from a “c+” rating to a “b-” rating in a research report on Friday, June 15th. Zacks Investment Research upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and set a $265.00 price target on the stock in a research report on Tuesday, May 22nd. Jefferies Financial Group restated a “buy” rating and set a $285.00 price target on shares of Cooper Companies in a research report on Friday, March 9th. Oppenheimer set a $265.00 price target on shares of Cooper Companies and gave the stock a “hold” rating in a research report on Friday, March 9th. Finally, Stephens restated a “hold” rating and set a $270.00 price target on shares of Cooper Companies in a research report on Friday, March 9th. Ten analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Cooper Companies currently has a consensus rating of “Hold” and a consensus price target of $265.36.

Cooper Companies Company Profile

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply